Angiogenesis and inflammation in ductal carcinoma in situ of the breast
暂无分享,去创建一个
[1] L. Happerfield,et al. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. , 1996, British Journal of Cancer.
[2] L. Norton,et al. Immunophenotype of intraductal carcinoma. , 1996, Archives of pathology & laboratory medicine.
[3] Anthony J. Guidi,et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. , 1995, Journal of the National Cancer Institute.
[4] W. Gregory,et al. Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markers , 1995, The Journal of pathology.
[5] J. Coyne,et al. Lymphocytic mastopathy associated with ductal carcinoma in situ of the breast , 1995, Histopathology.
[6] J. Sloane,et al. neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast. , 1995, Human pathology.
[7] P. Validire,et al. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. , 1994, Seminars in diagnostic pathology.
[8] M. J. van de Vijver,et al. Ductal carcinoma in situ: a proposal for a new classification. , 1994, Seminars in diagnostic pathology.
[9] Anthony J. Guidi,et al. Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.
[10] D N Poller,et al. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[11] F. Beuvon,et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. , 1994, Journal of the National Cancer Institute.
[12] F Pozza,et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.
[13] A. Harris,et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.
[14] A. Lee,et al. Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.
[15] V. Kosma,et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. , 1992, European journal of cancer.
[16] S. Ménard,et al. Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors , 1991, International journal of cancer.
[17] D. Levison,et al. Sclerosing lymphocytic lobulitis of the breast–evidence for an autoimmune pathogenesis , 1991, Histopathology.
[18] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[19] M. Silverstein,et al. Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice , 1990, Cancer.
[20] I. Schwartz,et al. Lymphocytic mastopathy. An autoimmune disease of the breast? , 1990, American journal of clinical pathology.
[21] S. Ashley,et al. Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysis , 1990, The Journal of pathology.
[22] F. Breedveld,et al. Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. , 1990, The Journal of rheumatology.
[23] H. Drexhage,et al. High endothelial venules present in lymphoid cell accumulations in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development. , 1989, The Journal of clinical endocrinology and metabolism.
[24] M. J. van de Vijver,et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. , 1988, The New England journal of medicine.
[25] R. Walker,et al. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast , 1987, The Journal of pathology.
[26] G. Riethmüller,et al. Infiltrating mononuclear cells in human breast carcinoma: Predominance of T4+ monocytic cells in the tumor stroma , 1985, International journal of cancer.
[27] C. Desmarais,et al. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. , 1983, Journal of the National Cancer Institute.
[28] T. Flotte,et al. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. , 1982, American journal of clinical pathology.
[29] W. Dupont,et al. A retrospective cohort study of histologic risk factors in breast cancer patients , 1982, Cancer.
[30] J. Haybittle,et al. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. , 1982, British Journal of Cancer.
[31] S. Brem,et al. Angiogenesis as a marker of preneoplastic lesions of the human breast , 1978, Cancer.
[32] M. Alderson,et al. The Relative Significance of Prognostic Factors in Breast Carcinoma , 1971, British Journal of Cancer.